267
Views
8
CrossRef citations to date
0
Altmetric
Articles

Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult Population

, M.D., Ph.D., , , M.D., , M.D., Ph.D. & , M.D., Ph.D.
Pages 217-224 | Received 28 Apr 2016, Accepted 29 Dec 2016, Published online: 02 Mar 2017

References

  • 23 Legal Medical Marijuana States and DC. n.d. Laws, Fees, and Possession Limits. http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881 ( accessed November 10, 2015).
  • Albertson, T. E., J. A. Chenoweth, D. K. Colby, and M. E. Sutter. 2016. The changing drug culture: Medical and recreational marijuana. FP Essentials 441:11–17.
  • Balkan Insight. 2015. Croatia legalizes marijuana for medical use. http://www.balkaninsight.com/en/article/croatia-first-balkan-county-to-legalize-medical-marijuana-10-15-2015-1 ( accessed October 23, 2015).
  • Basu, S., A. Ray, and B. N. Dittel. 2011. Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses. The Journal of Immunology 187 (11):5720–32. doi:10.4049/jimmunol.1102195.
  • Birdsall, S. M., T. C. Birdsall, and L. A. Tims. 2016. The use of medical marijuana in cancer. Current Oncology Reports 18 (7):40. doi:10.1007/s11912-016-0530-0.
  • Carlini, B. H., S. B. Garrett, and G. T. Carter. 2017. Medicinal cannabis: A survey among health care providers in Washington state. American Journal of Hospice and Palliative Care 34 (1):85–91. doi:10.1177/1049909115604669.
  • Charuvastra, A., P. D. Friedmann, and M. D. Stein. 2005. Physician attitudes regarding the prescription of medical marijuana. Journal of Addictive Disorders 24 (3):87–93. doi:10.1300/J069v24n03_07.
  • Dormann, C. F., J. Elith, S. Bacher, S. Bacher, C. Buchmann, G. Carl, G. Carré, J. R. García Marquéz, B. Gruber, B. Lafourcade, P. J. Leitão, T. Münkemüller, C. McClean, P. E. Osborne, B. Reineking, B. Schröder, A. K. Skidmore, D. Zurell, and S. Lautenbach. 2013. Collinearity: A review of methods to deal with it and a simulation study evaluating their performance. Ecography 36:27–46. doi:10.1111/j.1600-0587.2012.07348.x.
  • Ebert, T., Y. Zolotov, S. Eliav, O. Ginzburg, I. Shapira, and R. Magnezi. 2015. Assessment of Israeli physicians’ knowledge, experience and attitudes towards medical cannabis: A pilot study. Israel Medical Association Journal 17 (7):437–41.
  • European Monitoring Centre for Drugs and Drug Addiction. 2009. Serbia: Country overview. http://www.emcdda.europa.eu/system/files/publications/531/CO_Serbia_202235.pdf.
  • Global Burden of Disease Cancer Collaboration. 2015. The global burden of cancer 2013. Journal of the American Medical Association Oncology 1 (4):505–27.
  • Grotenherman, F. 2003. Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics 42:327–60. doi:10.2165/00003088-200342040-00003.
  • Grotenhermen, F. C. 2005. Cannabinoids. Current Drug Targets - CNS & Neurological Disorders 4:507–30.
  • Hosmer, D. W., and S. Lemeshow. 2000. Applied logistic regression, 2nd ed. New York, NY: Wiley, Inc.
  • InSerbia Network Foundation. 2014. Serbia could soon legalize marijuana: Report. http://inserbia.info/today/2014/09/serbia-could-soon-legalize-marijuana-report/.
  • Kolena, B., I. Petrovičová, T. Trnovec, T. Pilka, and G. Bičanová. 2016. Marijuana: Views on its medical use recorded at the Slovak social network. Journal of Drug Education. Advance online publication. doi:10.1177/0047237916646442.
  • Kondrad, E., and A. Reid. 2013. Colorado family physicians’ attitudes toward medical marijuana. The Journal of the American Board of Family Medicine 26:52–60. doi:10.3122/jabfm.2013.01.120089.
  • Manzanares, J., M. Julian, and A. Carrascosa. 2006. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Current Neuropharmacology 4 (3):239–57. doi:10.2174/157015906778019527.
  • Markovic-Denic, L., A. Cirkovic, S. Zivkovic, D. Stanic, and V. Skodric-Trifunovic. 2014. Cancer mortality in central Serbia. Journal of Balkan Union of Oncology 19 (1):273–77.
  • Mechoulam, R., and L. A. Parker. 2013. The endocannabinoid system and the brain. Annual Review of Psychology 64:21–47. doi:10.1146/annurev-psych-113011-143739.
  • Metts, J., S. Wright, J. Sundaram, and N. Hashemi. 2016. Medical marijuana: A treatment worth trying? Journal of Family Practice 65 (3):178–85.
  • Moeller, K., and B. Woods. 2015. Pharmacy students’ knowledge and attitudes regarding medical marijuana. American Journal of Pharmacy Education 79 (6):85. doi:10.5688/ajpe79685.
  • Parmar, J. R., B. D. Forrest, and R. A. Freeman. 2016. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Research in Social and Administrative Pharmacy 12 (4):638–54. doi:10.1016/j.sapharm.2015.09.002.
  • Rubens, M. 2014. Political and medical views on medical marijuana and its future. Social Work in Public Health 29 (2):121–31. doi:10.1080/19371918.2013.821351.
  • Suerken, C. K., B. A. Reboussin, E. L. Sutfin, K. G. Wagoner, J. Spangler, and M. Wolfson. 2014. Prevalence of marijuana use at college entry and risk factors for initiation during freshman year. Addictive Behavior 39 (1):302–07. doi:10.1016/j.addbeh.2013.10.018.
  • Svízenská, I., P. Dubový, and A. Sulcová. 2008. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures–a short review. Pharmacology Biochemistry and Behavior 90 (4):501–11. doi:10.1016/j.pbb.2008.05.010.
  • Sznitman, S. R., and A. L. Bretteville-Jensen. 2015. Public opinion and medical cannabis policies: Examining the role of underlying beliefs and national medical cannabis policies. Harm Reduction Journal 12:46. doi:10.1186/s12954-015-0082-x.
  • Volkow, N. D., R. D. Baler, W. M. Compton, and S. R. B. Weiss. 2014. Adverse health effects of marijuana use. New England Journal of Medicine 370 (23):2219–27. doi:10.1056/NEJMra1402309.
  • Wagner, G. A., V. A. Stempliuk, M. L. Zilberman, L. P. Barroso, and A. G. Andrade. 2007. Alcohol and drug use among university students: Gender differences. Revista Brasileira de Psiquiatria 29:123–29. doi:10.1590/S1516-44462006005000033.
  • WHO Regional Office for Europe. 2010. Evaluation of the organization and provision of primary care in Serbia: Primary care in the WHO European region. http://www.euro.who.int/__data/assets/pdf_file/0005/128849/e94554.pdf ( accessed October 30, 2015).
  • Wilkie, G., B. Sakr, and T. Rizack. 2016. Medical marijuana use in oncology: A review. JAMA Oncology. Advance online publication. doi:10.1001/jamaoncol.2016.0155.
  • Wilkinson, S. T., R. Radhakrishnan, and D. C. D’Souza. 2016. A systematic review of the evidence for medical marijuana in psychiatric indications. The Journal of Clinical Psychiatry 77 (8):1050–64. doi:10.4088/JCP.15r10036.
  • Ziemianski, D., R. Capler, R. Tekanoff, A. Lacasse, F. Luconi, and M. A. Ware. 2015. Cannabis in medicine: A national educational needs assessment among Canadian physicians. BMC Medical Education 15:52. doi:10.1186/s12909-015-0335-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.